Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 18

Showing 18 citing articles:

Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors
Zhao Yao, Taiqing Liu, Jingwen Wang, et al.
Biotechnology Advances (2025) Vol. 81, pp. 108546-108546
Closed Access | Times Cited: 1
Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment
Yulei Mu, Zhen Zhang, Huiqun Zhou, et al.
Biomaterials Science (2024) Vol. 12, Iss. 16, pp. 4045-4064
Closed Access | Times Cited: 5
siRNA tackles cancer: Immune checkpoint inhibitors and siRNA combinations
Andrew H. Coles
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102429-102429
Open Access
Nanotechnology for cancer immunotherapy
Xiaoqi Zheng, Bella B. Manshian, Stefaan J. Soenen
Elsevier eBooks (2025)
Closed Access
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
Scaffolds of Chitosan-metallic hybrids as antimicrobial wound dressing
Shengyu Zhang, Muhammad Ali, Farooq Nawaz, et al.
Journal of Molecular Liquids (2024), pp. 126541-126541
Closed Access | Times Cited: 2
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Sara Spaziani, Alessandro Esposito, Giovannina Barisciano, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access
Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
Mohammad S. Alzahrani, Bandar Almutairy, Yusuf S. Althobaiti, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1947-1964
Closed Access
Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment
Wenlu Yan, Ying Cao, Qi Yin, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1028-1028
Open Access
RNF26 up-regulates PD-L1 to regulate the cancer immune response in ccRCC
Weigang Ren, Jing Li, R Zeng, et al.
Biocell (2024) Vol. 48, Iss. 9, pp. 1323-1330
Open Access
Non-Coding RNAs and Innate Immune Responses in Cancer
Carlos Romero Díaz, María Teresa Hernández‐Huerta, Laura Pérez‐Campos Mayoral, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2072-2072
Open Access
Integrated bioinformatics analysis and validation identify KIR2DL4 as a novel biomarker for predicting chemotherapy resistance and prognosis in Colorectal Cancer
HuiE Zhuang, Yizhen Chen
Heliyon (2024) Vol. 10, Iss. 18, pp. e37896-e37896
Open Access
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer
Federico Rebaudi, Fabiana De Franco, Rayan Goda, et al.
Cancer Treatment Reviews (2024) Vol. 130, pp. 102831-102831
Open Access
LncRNA AF117829.1 is correlated with prognosis and immune infiltration and facilitates tumor progression by targeting OR7C1 in colorectal cancer
Tao Chen, Qiusheng Jiang, Zhenlin Wang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5347-5364
Open Access
Advances in Functional Organic-based Nanosystems for RNA Delivery, Targeting Different Organs
Mahzad Motalleb, Samira Malyen, Geyou Ao
Materials chemistry horizons. (2024) Vol. 3, Iss. 2, pp. 1-14
Open Access
Sequentially Activated Smart DNA Nanospheres for Photoimmunotherapy and Immune Checkpoint Blockade
Yu Chen, Yu Guo, Wen Cheng, et al.
Advanced Science (2024)
Open Access
How do varying concentrations and treatment durations of anti-PDL1 antibodies affect HCT116 cell viability, xenograft tumor size, and T cell activation, as measured by MTT assay, tumor weight, and IL-2 production, respectively?
Yusi Liu
MedScien (2024) Vol. 1, Iss. 10
Closed Access
Page 1

Scroll to top